Search research articles
Contact Us
Filters
Showing results (31-40 of 144) with videos related to
Page
of 15
Sort By:
Journal of Translational Medicine
|
May 24, 2008
Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viability
Alessandra Verdina, Irene Cardillo, Angela Nebbioso, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 16, 2009
Identification of 4-hydroxyquinolines inhibitors of p300/CBP histone acetyltransferases
Antonello Mai, Dante Rotili, Domenico Tarantino, et al.
Cancers
|
April 13, 2023
Targeting HDAC2-Mediated Immune Regulation to Overcome Therapeutic Resistance in Mutant Colorectal Cancer
Mariarosaria Conte, Annabella Di Mauro, Lucia Capasso, et al.
Journal of Translational Medicine
|
December 27, 2022
Retraction Note: Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viability
Alessandra Verdina, Irene Cardillo, Angela Nebbioso, et al.
International Journal of Molecular Sciences
|
January 11, 2022
Relevance of AIF/CypA Lethal Pathway in SH-SY5Y Cells Treated with Staurosporine
Mariarosaria Conte, Rosanna Palumbo, Alessandra Monti, et al.
Cancers
|
February 11, 2021
The Role of Necroptosis: Biological Relevance and Its Involvement in Cancer
Laura Della Torre, Angela Nebbioso, Hendrik G Stunnenberg, et al.
Epigenetics
|
December 16, 2014
ARHGEF3 controls HDACi-induced differentiation via RhoA-dependent pathways in acute myeloid leukemias
Loredana D'Amato, Carmela Dell'Aversana, Mariarosaria Conte, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 25, 2008
Identification of long chain alkylidenemalonates as novel small molecule modulators of histone acetyltransferases
Gianluca Sbardella, Sabrina Castellano, Caterina Vicidomini, et al.
Frontiers in Pharmacology
|
September 25, 2018
3-Chloro-<i>N</i>'-(2-hydroxybenzylidene) benzohydrazide: An LSD1-Selective Inhibitor and Iron-Chelating Agent for Anticancer Therapy
Federica Sarno, Chiara Papulino, Gianluigi Franci, et al.
Molecules (Basel, Switzerland)
|
February 13, 2025
Epigallocatechin Gallate (EGCG): Pharmacological Properties, Biological Activities and Therapeutic Potential
Lucia Capasso, Luigi De Masi, Carmina Sirignano, et al.
Page
of 15
Search research articles
Search
Showing results (31-40 of 144) with videos related to
Sort By:
Page
of 15
Journal of Translational Medicine
|
May 24, 2008
Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viability
Alessandra Verdina, Irene Cardillo, Angela Nebbioso, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 16, 2009
Identification of 4-hydroxyquinolines inhibitors of p300/CBP histone acetyltransferases
Antonello Mai, Dante Rotili, Domenico Tarantino, et al.
Cancers
|
April 13, 2023
Targeting HDAC2-Mediated Immune Regulation to Overcome Therapeutic Resistance in Mutant Colorectal Cancer
Mariarosaria Conte, Annabella Di Mauro, Lucia Capasso, et al.
Journal of Translational Medicine
|
December 27, 2022
Retraction Note: Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viability
Alessandra Verdina, Irene Cardillo, Angela Nebbioso, et al.
International Journal of Molecular Sciences
|
January 11, 2022
Relevance of AIF/CypA Lethal Pathway in SH-SY5Y Cells Treated with Staurosporine
Mariarosaria Conte, Rosanna Palumbo, Alessandra Monti, et al.
Cancers
|
February 11, 2021
The Role of Necroptosis: Biological Relevance and Its Involvement in Cancer
Laura Della Torre, Angela Nebbioso, Hendrik G Stunnenberg, et al.
Epigenetics
|
December 16, 2014
ARHGEF3 controls HDACi-induced differentiation via RhoA-dependent pathways in acute myeloid leukemias
Loredana D'Amato, Carmela Dell'Aversana, Mariarosaria Conte, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 25, 2008
Identification of long chain alkylidenemalonates as novel small molecule modulators of histone acetyltransferases
Gianluca Sbardella, Sabrina Castellano, Caterina Vicidomini, et al.
Frontiers in Pharmacology
|
September 25, 2018
3-Chloro-<i>N</i>'-(2-hydroxybenzylidene) benzohydrazide: An LSD1-Selective Inhibitor and Iron-Chelating Agent for Anticancer Therapy
Federica Sarno, Chiara Papulino, Gianluigi Franci, et al.
Molecules (Basel, Switzerland)
|
February 13, 2025
Epigallocatechin Gallate (EGCG): Pharmacological Properties, Biological Activities and Therapeutic Potential
Lucia Capasso, Luigi De Masi, Carmina Sirignano, et al.
Page
of 15